Access Denied!!!

It appears that you are using a private browser which blocks some scripts necessary for this page to function properly. As a result, you may experience limited functionality or the page may not work at all.

To access this page, please consider using a different browser or switch to the standard version of Firefox.

Thank you for your understanding.

Access Full Project

Publicly Funded

Privately Funded

Bidding Soon

Documents Available

Addenda Available

Post-Bid

Post-Bid

Saving Project...

Full details on over 250,000 Projects including 2000 updated daily available to subscribers

No Information to Display

March 26, 2025

No Information to Display

1 Marcus Ave

New Construction, Site Work

No Information to Display

$35,000,000.00

Public - State/Provincial

img_map_placeholder

1 Marcus Ave, Floral Park, NY

We’ve obtained documents for this project and are currently processing them.

Subscribe to View Full Documents

The New York State Urban Development Corporation d/b/a Empire State Development ("ESD" or the "Corporation"), a corporate governmental agency of the State of New York, constituting a political subdivision and public benefit corporation, pursuant to this request for proposals ("RFP") seeks proposals from qualified parties for the development of a cell and gene therapy ("CGT") hub (the "Long Island CGT Center" or the "Project") that will be home to organizations providing services required to support the research, development, and manufacture of new CGTs at a site in Nassau County, Long Island. Deadline to Submit Questions Friday, Friday, February 9, 2024 ESD to Respond to Questions Friday, Friday, February 23, 2024 All contacts/inquiries shall be made by email to the following address: CGTHubLongIslandRFP@esd.ny.gov Designated Contacts for this Procurement: Primary Contact: John F. Discolo Secondary Contact: Ralph Volcy Respondents should propose uses that will advance the Development Objectives described in Section IV below. Proposals shall, at minimum, meet the required objectives and include submission of the required Proposal materials in order to be considered responsive, including the delivery and operation of an approximately 200,000 gsf facility focused on the development, clinical trials for, commercialization, manufacture, and related endeavors including an incubator targeted to CGT startups and companies, of cell and gene therapies, as more fully described in Section V, Required Proposal Components, below. Interviews (if necessary) TBD Announcement of Successful Bidder TBD Anticipated Contract Start Date TBD

3 Record(s)

Subscribe to Get All Contact Details

Trades

Division 00 - Lorem Ipsum

Division 00 - Lorem Ipsum

Lorem, Ipsum, Dolor, Sit amet
Subscribe to See All Trade Details

You’ve Reached the Free View Limit

Want to see more project and bidder data in your market? Check out our product options and see what works best for you and your business.

Come back in [[refresh_days]] to get [[project_count]] more free projects.